O-glycan-dependent immunotherapy for cancer

Ended Project Grant Awarded Last action

Award ID
R41CA233111
Recipient
Awarding agency
Obligated
$300,614

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Originally
Place of performance
California, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $2,084
Amendment $0
Original award $298,530

Quick answers

Who received award R41CA233111?

R41CA233111 was awarded to Glytr Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on September 18, 2018.

How much is award R41CA233111 worth?

$300,614 has been obligated on R41CA233111.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award